Bought
Maintained
Sold
Other funds holding VSTM
PIM
DVC
TCM
MAM
BFA
UBS's VSTM Position: Q3 2014 in Review
UBS increased its Verastem (VSTM) stake by 63% in Q3 2014, buying an estimated $2.21M and bringing the position to 54,702 shares worth $5.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1914.
UBS first reported a position in VSTM in Q2 2013 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold VSTM as of Q3 2014.
- UBS held 54,702 shares of Verastem worth $5.59M as of Q3 2014.
- UBS bought 21,080 Verastem shares in Q3 2014, an estimated $2.21M.
- Verastem made up ﹤0.01% of UBS's portfolio in Q3 2014, its #1914 holding.
- UBS first reported a position in Verastem in Q2 2013 and has held it in 6 quarters since.
- 69 funds tracked by Wall St. Rank held Verastem as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.